BPA for mycapssa, juxtapid, myalept
Ended Awarded Last action
- Contract number
- 36E79723A0006
- Awardee
-
Amryt Pharmaceuticals Inc. UEI WD35CGRUEWS7
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $1,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Amryt Pharmaceuticals Inc., a foreign-owned, for-profit organization, on November 5, 2022. The potential value of the BPA is $1,000,000. No set-aside was used.
The BPA is for a single award and permits ordering of Mycapssa, Juxtapid, and Myalept through March 14, 2024. Mycapssa, Juxtapid, and Myalept are pharmaceutical products used to treat certain rare diseases. The Department of Veterans Affairs National Acquisition Center aims to establish competitive pricing and streamline the procurement process for these specialized drugs through this contracting vehicle.
As the largest integrated healthcare system in the United States, the Department of Veterans Affairs maintains programs to ensure veterans have access to treatments for difficult to manage health conditions. This BPA supports those efforts by pre-qualifying a supplier and establishing terms for three specialty medications, expediting ordering when a clinical need arises. The foreign-owned awardee will deliver the pharmaceuticals to Department of Veterans Affairs medical centers and clinics nationwide through task orders issued against the agreement.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79723A0006?
36E79723A0006 was awarded to Amryt Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on November 5, 2022.
How much is contract 36E79723A0006 worth?
36E79723A0006's own ceiling is $1,000,000.
Who can order from contract 36E79723A0006?
36E79723A0006 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79723A0006 under another contract?
Yes. 36E79723A0006 is a blanket purchase agreement under 36F79722D0228, a federal supply schedule.
Was contract 36E79723A0006 competed?
The extent of competition for 36E79723A0006 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV